14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HH vs AMS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, American Shared Hospital Services (AMS) is the stronger overall head-to-head candidate over HH (HH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HH carries a Unified Composite Score of 54.7/100 (HOLD) at $24.97 (N/M Forward P/E, N/A operating margin), whereas AMS carries 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin).
Composite vs. Pillar Nuance: While HH currently prints a higher short-term Unified Composite Score (54.7/100 HOLD vs. AMS 33.8/100 SELL), AMS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-7.4% vs. N/A operating margin) and revenue trajectory (+19.2% vs. N/A YoY).
Technical & Structure Timing Caution: HH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile AMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HH vs AMS. Trailing 12-month operating profitability (HH N/A vs AMS -7.4%) and valuation multiples (HH N/M vs AMS 44.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ HH vs AMS Key Questions & Quantitative Answers
As of Nov 16, 2026, American Shared Hospital Services (AMS) is the stronger overall head-to-head candidate over HH (HH) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HH carries a Unified Composite Score of 54.7/100 (HOLD) at $24.97 (N/M Forward P/E, N/A operating margin), whereas AMS carries 33.8/100 (SELL) at $1.07 (44.6x Forward P/E, -7.4% operating margin). Composite vs. Pillar Nuance: While HH currently prints a higher short-term Unified Composite Score (54.7/100 HOLD vs. AMS 33.8/100 SELL), AMS captures the overall institutional head-to-head verdict (7–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-7.4% vs. N/A operating margin) and revenue trajectory (+19.2% vs. N/A YoY). Technical & Structure Timing Caution: HH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile AMS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AMS leads the Growth & Scale pillar: HH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with AMS at +19.2% YoY revenue growth and -38.1% YoY earnings growth on $30M TTM revenue (34.8% gross margin, -7.4% operating margin). On trailing 12-month operating scale, HH generates N/A in USD-normalized revenue versus $30M for AMS. In operating R&D and SG&A reinvestment, HH deploys N/A (0 90-day corporate R&D disclosures) versus 42.2% of Rev ($13M) (0 disclosures) for AMS.
AMS screens cheaper on headline valuation multiples. HH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AMS trades at 44.6x Forward P/E, 44.6x Trailing P/E, N/M PEG, and 0.8x EV/Revenue (-3.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HH (N/A ROE) versus AMS (-12.1% ROE) capital efficiency.
In options market volatility and institutional positioning, HH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, AMS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.18β · 46% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.